|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||
| Investments at fair value | ||||||||||||||
| Non-controlled/non-affiliated | ||||||||||||||
| Noncontrolled/affiliated | ||||||||||||||
| Controlled/affiliated | ||||||||||||||
| Total investments at fair value | ||||||||||||||
| Cash and cash equivalents | ||||||||||||||
| Cash | ||||||||||||||
| Cash equivalents | ||||||||||||||
| Total cash and cash equivalents | ||||||||||||||
| Interest receivable from non-controlled/non-affiliated investments | ||||||||||||||
| Non-controlled/non-affiliated | ||||||||||||||
| Noncontrolled/affiliated | ||||||||||||||
| Total interest receivable from non-controlled/non-affiliated investments | ||||||||||||||
| Dividend receivable from non-controlled/non-affiliated investments | ||||||||||||||
| Deferred financing costs | ||||||||||||||
| Deferred offering costs | ||||||||||||||
| Derivative assets, at fair value (Note 6) | ||||||||||||||
| Receivable for investments | ||||||||||||||
| Other assets | ||||||||||||||
| Total assets | ||||||||||||||
| LIABILITIES | ||||||||||||||
| Debt (net of unamortized debt issuance costs of $93,670 and $90,359 at June 30, 2026 and December 31, 2025, respectively) | ||||||||||||||
| Payable for investments purchased | ||||||||||||||
| Interest payable | ||||||||||||||
| Derivative liabilities, at fair value (Note 6) | ||||||||||||||
| Due to affiliates | ||||||||||||||
| Distribution payable (Note 9) | ||||||||||||||
| Payable for share repurchases (Note 9) | ||||||||||||||
| Management fees payable (Note 3) | ||||||||||||||
| Income based incentive fees payable (Note 3) | ||||||||||||||
| Capital gains incentive fees payable (Note 3) | ||||||||||||||
| Shareholder servicing and/or distribution fees payable | ||||||||||||||
| Accrued expenses and other liabilities | ||||||||||||||
| Total liabilities | ||||||||||||||
| NET ASSETS | ||||||||||||||
| Common Shares, $0.01 par value (493,375,252 and 493,104,572 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively) | ||||||||||||||
| Additional paid in capital | ||||||||||||||
| Distributable earnings (loss) | ||||||||||||||
| Total net assets | ||||||||||||||
| Total liabilities and net assets |
Loading...
